Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.100
-0.020 (-1.79%)
At close: May 12, 2025, 4:00 PM
1.110
+0.010 (0.90%)
After-hours: May 12, 2025, 7:59 PM EDT
PACB Employees
Pacific Biosciences of California had 575 employees as of December 31, 2024. The number of employees decreased by 221 or -27.76% compared to the previous year.
Employees
575
Change (1Y)
-221
Growth (1Y)
-27.76%
Revenue / Employee
$264,969
Profits / Employee
-$1,143,910
Market Cap
330.05M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PACB News
- 13 hours ago - PacBio Board Independent Investigation Concludes Allegations Unsubstantiated - GlobeNewsWire
- 4 days ago - Pacific Biosciences of California, Inc. (PACB) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - PacBio Announces First Quarter 2025 Financial Results - GlobeNewsWire
- 7 days ago - First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand - GlobeNewsWire
- 14 days ago - PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry - GlobeNewsWire
- 20 days ago - Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa - GlobeNewsWire
- 4 weeks ago - PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million - GlobeNewsWire
- 5 weeks ago - PacBio Grants Equity Incentive Award to New Employee - GlobeNewsWire